20/09/2018. Disclosures. Frédéric Lapostolle Urgences - SAMU 93, UF Recherche Hôpital Avicenne & Université Paris 13, Bobigny
|
|
- Sandra Wood
- 5 years ago
- Views:
Transcription
1 Disclosures Speaker Astra-Zeneca, Bayer, BMS, Boehringer-Ingelheim, Daiichy-Sankyo, Lilly, Medtronic, Merck-Serono, Mundipharma, Novartis, Pfizer, Teleflex, The Medicine Company Investigator Frédéric Lapostolle Urgences - SAMU 93, UF Recherche Hôpital Avicenne & Université Paris 13, Bobigny Astra-Zeneca, Merck-Serono, Mundipharma, Novartis, Teleflex Frédéric Lapostolle Urgences - SAMU 93, UF Recherche Hôpital Avicenne & Université Paris 13, Bobigny 1 Frédéric Lapostolle Urgences - SAMU 93, UF Recherche Hôpital Avicenne & Université Paris 13, Bobigny 1
2 1 Human Toxicity Excerpts: /SIGNS AND SYMPTOMS/ Ingestion of five or more grams of nutmeg causes acute nutmeg poisoning, which includes giddiness, hallucinations, and feelings of depersonalization. Symptoms usually appear three to six hours after ingestion of 1 3 whole nutmegs or 5 15 gm of the grated spice. Recovery usually occurs within 24 hours. Nevertheless, duration of action may extend beyond several days and even include death. /Nutmeg/ [Green RC, Jr; JAMA 171 (10): (1959); Painter JC et al; Clin Toxicol 4 (1): 1 4 (1971)] **PEER REVIEWED** Human Toxicity Excerpts: /SIGNS AND SYMPTOMS/ Ingestion of five or more grams of nutmeg causes acute nutmeg poisoning, which includes giddiness, hallucinations, and feelings of depersonalization. Symptoms usually appear three to six hours after ingestion of 1 3 whole nutmegs or 5 15 gm of the grated spice. Recovery usually occurs within 24 hours. Nevertheless, duration of action may extend beyond several days and even include death. /Nutmeg/ [Green RC, Jr; JAMA 171 (10): (1959); Painter JC et al; Clin Toxicol 4 (1): 1 4 (1971)] **PEER REVIEWED** 2
3 1 3
4 2 2 Boyer, NEJM, 2005 Boyer, NEJM, 2005 Serotonin syndrome 4
5 2 Coma Bradypnea Myosis 5
6 Diagnostic strategy Diagnostic strategy Diagnostic strategy Diagnostic strategy 6
7 Diagnostic strategy Diagnostic strategy Diagnostic strategy EKG heart rate blood pressure It s not a poisoning There is another toxic (to identify) There is a complication (to identify) Myosis EKG heart rate blood pressure Interaction with diagnostic, severity and outcome Aspiration Rhabdomyolysis Myosis Rhabdomyolysis Aspiration 7
8 blood EKG heart pressure 2 rate Congruence = Security Myosis
9 3 Result likely to influence treatment Proudfoot, Critical Care Toxicology, Result likely to influence treatment Proudfoot, Critical Care Toxicology, Acetaminophen Isopropanol 3 Acetaminophen Isopropanol Carboxyhemoglobin Methanol Carboxyhemoglobin Methanol Digoxin Methemoglobin Digoxin Methemoglobin Ethylene glycol Phenobarbital Ethylene glycol Phenobarbital Iron Salicylates Iron Salicylates Lithium Theophylline Lithium Theophylline Proudfoot, Critical Care Toxicology, 2005 Proudfoot, Critical Care Toxicology, 2005 Brent, NEJM, 2009 Brent, NEJM, 2009 Finkle, Acid-base and Electrolyte disorders,
10 Equimolar curative neutralization Asystole Ventricular dysrhythmia Heart rate < 40/min after intravenous atropine Serum potassium > 5.0 mmol/l Semi-equimolar prophylactic neutralization Age>55 Cardiac disease Heart rate <60/min after atropine Second or third degree block Serum potassium > 4.5mmol/L Lapostolle, Crit Care Toxicology, Supportive treatment Decontamination / drug removal Antidote treatment 10
11 Clinical Toxicol, 2005 Clinical Toxicol, 2005 Clinical Toxicol, 2005 Clinical Toxicol,
12 Antidotes Clinical Toxicol, 2004 Antidotes with alternative treatment Antidotes with alternative treatment Antidotes with alternative treatment Antidote without alternative treatment 12
13 Simmons, Drug Alcohol Depend,
14 Dart, Ann Emerg Med, 2017 Dart, Ann Emerg Med, 2017 California Health and Human Services Agency Department of Public Health. Hospital Administrative Penalties 14
15 Make exceptional treatment available 4 4 Make exceptional treatment available 1&2 The doubt kills 1&2 The doubt kills 3 Toxicologic screening is not useful
16 1&2 3 The doubt kills Toxicologic screening is not useful 3 Make exceptional treatment available 16
DES in primary PCI for STEMI: contra
DES in primary PCI for STEMI: contra Philippe Gabriel Steg Department of Cardiology Hôpital Bichat Claude Bernard, AP-HP Université Paris VII Denis Diderot INSERM U-698 Paris, France Ph. Gabriel Steg -
More informationClinical Pathway: Management Of The Life-Threatening Overdose
Clinical Pathway: Management Of The Life-Threatening Overdose Intravenous access Oxygen Pulse oximetry n-invasive blood pressure monitoring Accu-Check ECG monitoring and ECG Chest x-ray Respiratory depression?
More informationEpisode 90 Low and Slow Poisoning
Hyperkalemia Myxedema coma Spinal cord injury Hypothermia Episode 90 Low and Slow Poisoning With Drs. Margaret Thompson & Emily Austin Prepared by Dr. Keerat Grewal, edited by Dr. Anton Helman, Jan 2017
More informationUses Location(s) Par Levels a Location(s) Par Levels. Min: 18 Max: 36. Min: 22 Max: 33. Talyst (Refrig) Talyst (Refrig) Min: 2 b Talyst (Refrig)
U N C M E D I C A L C E N T E R G U I D E Antidotes Used in Poisonings and Ingestions The purpose of this guide is to describe the locations and quantities of antidotes to be maintained at UNC Medical
More informationSUPPLEMENTARY DATA. Telediab Study Group :
Telediab Study Group : Guillaume Charpentier, MD, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France Centre d Études et de Recherches pour l Intensification du Traitement du Diabète
More information2016 ESC Guidelines for the Diagnosis and treatment of Acute & Chronic Heart Failure
2016 ESC Guidelines for the Diagnosis and treatment of Acute & Chronic Heart Failure AHF - Initial phase in the emergency department: diagnosis and management Héctor Bueno, MD, PhD, FESC, FAHA Department
More informationHospital Ranking Based on Discharge Prescriptions After Acute Myocardial Infarction: A National Assessment over Three Consecutive Years
Hospital Ranking Based on Discharge Prescriptions After Acute Myocardial Infarction: A National Assessment over Three Consecutive Years François Schiele 1, Frédéric Capuano 2, Geneviève Derumeaux 3, Nicolas
More informationWhat is the diagnosis? CASE STUDY no 1. What is the diagnosis? CASE STUDY no 1 USE OF THE LABORATORY WHEN MANAGING THE POISONED PATIENT
USE OF THE LABORATORY WHEN MANAGING THE POISONED PATIENT USE OF THE LABORATORY WHEN Phil Routledge Dept Pharmacology, Therapeutics and Toxicology Wales College of Medicine Cardiff University WALES, UK
More informationSTEMI Linee guida ESC Maddalena Lettino, Italy
STEMI Linee guida ESC 2017 Maddalena Lettino, Italy Disclosure Speaker fee: Aspen, Astra Zeneca, BMS, Boehringer, Eli Lilly, DaichiiSankio, Bayer, Pfizer, Sanofi Advisory board member: Astra Zeneca, Eli
More informationINTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:
Care of the Poisoned Patient WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017 RN.ORG, S.A.,
More informationEDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing
EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE
More informationAn Update from EXTRIP
Extracorporeal Removal in Poisoning An Update from EXTRIP Dr Paul I Dargan Clinical Toxicology Guy s and St Thomas NHS Foundation Trust London, UK Disclosures Expenses (no honorarium) covered by the EXTRIP
More informationThe RealiseAF registry:
The RealiseAF registry: An International, observational, cross-sectional survey evaluating atrial fibrillation management and the cardiovascular risk profile of AF patients initial results PG.Steg on behalf
More informationEpic Labs Orderable As STAT PRIORITY As of 06/22/2016
ABG+HB(CORDARTERIAL) - BABY A ABG+HB(CORD ARTERIAL)- BABY B ABG+HB(CORD ARTERIAL)- BABY C ACETAMINOPHEN LEVEL ALANINE AMINOTRANSFERASE (ALT) ALBUMIN, FLUID ALBUMIN, PLEURAL FLUID ALBUMIN, SYNOVIAL FLUID
More informationRole of toxicological analysis in the management of poisonings with cardiotoxicants Bruno Mégarbane
Role of toxicological analysis in the management of poisonings with cardiotoxicants Bruno Mégarbane Réanimation Médicale et Toxicologique, INSERM, U705, Université Paris - Diderot Hôpital Lariboisière,
More informationA.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany
Impact of Interventional Versus Conservative Approach on 5-Year-Mortality of Patients With Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry A.K. Gitt,
More informationAFATINIB FOLLOWED BY OSIMERTINIB IN REAL-WORLD PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC: AN OBSERVATIONAL STUDY
AFATINIB FOLLOWED BY OSIMERTINIB IN REAL-WORLD PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC: AN OBSERVATIONAL STUDY Maximilian J. Hochmair, 1 Alessandro Morabito, 2 Desiree Hao, 3 Cheng-Ta Yang, 4 Ross A.
More informationUpdate in Poison Management. Update in Poison Management. Antidote Use. Fomepizole. Pediatric Ingestions 1. No financial disclosures
Update in Poison Management No financial disclosures Robert J. Hoffman, MD,MS FACMT, FACEP, FAAEM, FAAP Department of Emergency Medicine Albert Einstein College of Medicine New York, New York Update in
More informationSimilar risk of malignancy with insulin glargine and neutral protamine Hagedorn
Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,
More informationDecision for fibrinolysis or primary PCI in the prehospital phase
Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,
More informationUncommon Indications for Extracorporeal Toxin Removal (ECTR) Robert S. Hoffman, MD Director, Division of Medical Toxicology NYU School of Medicine
Uncommon Indications for Extracorporeal Toxin Removal (ECTR) Robert S. Hoffman, MD Director, Division of Medical Toxicology NYU School of Medicine Disclosure I have no financial or academic conflicts of
More informationUniversity of Leipzig Heart Center
Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock Holger
More informationPediatric Toxicologic Emergencies
Pediatric Toxicologic Emergencies Martin Belson, MD Department of Pediatrics Georgia Poison Center Emory University I. Epidemiology A. Over 2 million poison exposures reported in 2003 B. 53% of these exposures
More informationPOISON ANTIDOTE DOSE* COMMENTS
Antidotes Acetaminophen N-acetylcysteine 140 mg/kg initial oral dose, followed Most effective within 16 24 hr; may by 70 mg/kg every 4 hr 17 doses be useful after chronic intoxication or intravenously
More informationEfficacy and Safety of Alirocumab in Patients with Hypercholesterolemia not on Statin Therapy: the ODYSSEY CHOICE II Study
Efficacy and Safety of Alirocumab in Patients with Hypercholesterolemia not on Statin Therapy: the ODYSSEY CHOICE II Study Erik Stroes, 1 John Guyton, 2 Michel Farnier, 3 Norman Lepor, 4 Fernando Civeira,
More informationChapter 23. Toxicology Principles in the Management of Acute Poisonings
Chapter 23 Toxicology Principles in the Management of Acute Poisonings Toxicology Principles in the Management of Acute Poisonings The basic principles of toxicology come into play in the rational management
More informationOral poisoning: an update
: an update Catherine Ward MBBS BSc Hons FRCA Mark Sair PhD MRCP FRCA Key points The mainstay treatment of poisoning is resuscitation and supportive care. Poisoning should be considered in any patient
More informationA Clinical Context Report
Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and
More informationA Future for the IABP in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany
A Future for the in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany Disclosures Funding: German Research Foundation German Heart Research
More informationBasics and Decontamination in Clinical Toxicology
! Klinikum rechts der Isar Technische Universität München Basics and Decontamination in Clinical Toxicology! Toxi-Latin Porto Alegre 2014 Florian Eyer Toxicological Department 2nd Medizinische Klinik Klinikum
More informationNAME CTS AFFILIATION DISCLOSURE UPDATED
NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian
More informationPost Hoc Analysis of the PARADIGM Heart Failure Trial:
Post Hoc Analysis of the PARADIGM Heart Failure Trial: Pulse Pressure and Outcomes in Heart Failure with Reduced Ejection Fraction Chen-Huan Chen, M.D. Professor, Department of Medicine, National Yang-Ming
More informationGestione della DAPT post-pci in chirurgia cardiaca e non cardiaca
Gestione della DAPT post-pci in chirurgia cardiaca e non cardiaca Francesco Saia Polo Cardio-Toraco-Vascolare Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola Malpighi Bologna DISCLOSURE
More informationin patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017
Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients with diabetes, nephropathy
More informationTargeted Therapies in the Management of Non-Small Cell Lung Cancer. A Multi-Disciplinary Approach
Targeted Therapies in the Management of Non-Small Cell Lung Cancer A Multi-Disciplinary Approach Course Faculty Medical Oncologists: Dr. Barb Melosky British Columbia Cancer Agency, Vancouver, BC Dr. Jeff
More informationNeither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity.
CRACKCast E160 Lithium Key concepts; The clinical pattern of acute and chronic toxicity is different. Gastrointestinal symptoms occur early and neurological toxicity manifest late in acute toxicity. Neurological
More informationToxicology & ECTR. PYNICU Friday lecture Dec 2, 2016 Dr TY Li / Dr HP Shum
Toxicology & ECTR PYNICU Friday lecture Dec 2, 2016 Dr TY Li / Dr HP Shum Outline History of ECTR in poisoning Outline of method of ECTR Development of EXTRIP RecommendaMons of EXTRIP Treatment pyramid
More informationQuoi de neuf en cardio-gériatrie? Pr Olivier Hanon Hôpital Broca, Paris
Quoi de neuf en cardio-gériatrie? Pr Olivier Hanon Hôpital Broca, Paris Déclaration de relations professionnelles et liens d intérêt Novartis, Daiichi-Sankyo, Boehringer-Ingelheim, Bayer, BMS, Pfizer,
More informationClinical and Economic Value of Rivaroxaban in Coronary Artery Disease
CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban
More informationUnderstanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal
Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria
More informationNOACs Update PD Dr. Jan Steffel Leitender Arzt, Klinik für Kardiologie Co-Leiter Rhythmologie Universitätsspital Zürich
NOACs Update 2016 PD Dr. Jan Steffel Leitender Arzt, Klinik für Kardiologie Co-Leiter Rhythmologie Universitätsspital Zürich Conflict of Interest Statement o o o o Consulting: Amgen, Astra Zeneca, AtriCure,
More informationDancing with Death: MDMA, PMMA and other 4 letter words
Dancing with Death: MDMA, PMMA and other 4 letter words Mark Yarema, MD FRCPC Poison and Drug Information Service Alberta Health Services AARC Community Intervention Series March 15, 2016 Objectives At
More informationImplications of Universal MI Definition for Clinical Trials
Implications of Universal MI Definition for Clinical Trials Stephen D. Wiviott, MD Chairman, Clinical Events Committee TIMI Study Group Cardiovascular Division Brigham and Women s Hospital Harvard Medical
More informationWhat s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)
What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE Marc Ferrini (Lyon Fr) Palermo (I) 1 04 2017 Consulting Fees, Honoraria: BAYER PHARMA BOEHRINGER INGELHEIM BRISTOL MEYERS
More informationStroke and Headache Headache and Stroke
Stroke and Headache Headache and Stroke Hans-Christoph Diener Senior Professor of Clinical Neurosciences University Duisburg-Essen Tobias Kurth Institute of Public Health Charité Universitätsmedizin Berlin
More informationThis article is a CME/CE certified activity. To earn credit for this activity visit:
Novel Perspectives on Type 2 Diabetes: Traditional and Emerging Therapies and the Potential Role of the Kidneys This article is a CME/CE certified activity. To earn credit for this activity visit: www.medscape.org/lecture/t2dm-therapies
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Charcodote 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Activated charcoal 200mg/ml 3. PHARMACEUTICAL FORM Oral suspension 4. CLINICAL
More informationCLINICAL TOXICOLOGY. Gábor Zacher Dept. Emergency Medicine Central Military Hospital
CLINICAL TOXICOLOGY Gábor Zacher Dept. Emergency Medicine Central Military Hospital LEARNING OBJECTIVES To understand the general principles of clinical toxicology To know general factors that influence
More informationEAPCI: Biodegradable Scaffolds-Writers 2016
Baumbach Andreas Byrne Robert - Medicines Company : Drugs (2015) - Abbott Vascular : Stents (2015) - Abbott Vascular : Stent (2015) - Boston Scientific : Medical devices (2015) - Biotronik : Medical devices
More informationGlucose Control and Prevention of Cardiovascular Disease
Glucose Control and Prevention of Cardiovascular Disease Dr Peter A Senior BMedSci MBBS PhD FRCP(E) Associate Professor, Director Division of Endocrinology, University of Alberta Diabetes Update+, March
More informationCyanide Poisoning. Daniel Shodell MD, MPH. Anne Arundel County DOH,
Cyanide Poisoning Daniel Shodell MD, MPH Anne Arundel County DOH, 2004 1 Learning objectives Describe the clinical syndrome, treatment, and epidemiology of cyanide Identify the key public health agency
More informationThe impact of antiretroviral drugs on Cardiovascular Health
The impact of antiretroviral drugs on Cardiovascular Health José López-Sendón Hospital Universitario La Paz. IdiPaz Madrid. Spain Research grants and honoraria from (research committees, clinical trials,
More information2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much?
2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much? Dr. Shelley Zieroth University of Manitoba @ShelleyZieroth @CanHFSociety Disclosures Consulting/Advisory Board: Amgen, Astra
More informationHow clinically important are the results of the large trials in hypertension?
How clinically important are the results of the large trials in hypertension? Stéphane LAURENT, MD, PhD, FESC Pharmacology Department and PARCC / INSERM U970 Hôpital Européen Georges Pompidou, Université
More informationnephropathy and/or chronic kidney disease Summary of recommendations
July 2017 Guidelines: Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and reninangiotensin-aldosterone system blockade in patients
More informationA General Approach to the Poisoned Patient.
A General Approach to the Poisoned Patient. Remember: "The Dose Alone Makes the Poison" Obtaining a History A. History: Obtaining a good history is critical in order to provide sound advice. In attempting
More informationUse of hemodialysis and hemoperfusion in poisoned patients
http://www.kidney-international.org & 2008 International Society of Nephrology original article see commentary on page 1231 Use of hemodialysis and hemoperfusion in poisoned patients William J. Holubek
More informationEvidence grades for the recommendations
Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy
More informationOpioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:
Opioid Overdose Best Practices Guideline Table of Contents A. General description B. Typical signs and symptoms C. Expected course D. Making the diagnosis E. Recommended treatment F. Criteria for hospital
More informationMidMichigan Health LABORATORY POLICY Title: Effecti ve te: Key Words: places: Category: Applicability: reference laboratory
Page 1 of 5 PURPOSE This policy describes the responsibilities for determining which tests performed and or provided by the MidMichigan Health Laboratories fulfill the criteria for critical values / critical
More informationWhat is Happening in Clinical Trials for Small Cell Lung Cancer?
What is Happening in Clinical Trials for Small Cell Lung Cancer? Joshua Bauml, MD Assistant Professor of Medicine Perelman School of Medicine at the University of Pennsylvania Financial Disclosures Research/Grant
More informationToxicologic Emergencies. Objectives. Priorities. CAPA 2015 Annual Conference
Toxicologic Emergencies Jed Grant, MPAS, PA-C Staff PA, Emergency Department, Mercy San Juan Medical Center, Sacramento, CA Assistant Professor, University of the Pacific PA Program, Sacramento, CA Vice
More informationINTERESTING RECENT TOXICOLOGY CASES CASE #1 EXPOSURE CASE #1 CASE #1 BP-74/48 P-104 T-97.6 DIVISION OF TOXICOLOGY UCSD
INTERESTING RECENT TOXICOLOGY CASES Aaron Schneir MD Assistant Professor Division of Medical Toxicology Department of Emergency Medicine DIVISION OF TOXICOLOGY UCSD SAN DIEGO DIVISION CALIFORNIA POISON
More informationAntiplatelet Agents in Acute Coronary Syndromes, NSTE-ACS
Antiplatelet Agents in Acute Coronary Syndromes, NSTE-ACS Is There Still a Role for IV Antiplatelet Agents (Cangrelor, GPIIbIIIA inhibitors)? François Schiele, MD, PhD Department of Cardiology, University
More informationThe Poison Center: A Valuable Resource For All Presented by The University of Kansas Hospital Poison Control Center
The Poison Center: A Valuable Resource For All Presented by The University of Kansas Hospital Poison Control Center Stefanie Baines Education Coordinator 913-588-0152 sbaines@kumc.edu Benefits of the poison
More informationIndustry Relationships and Institutional Affiliations
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated daily statin: results from the ODYSSEY COMBO II study Christopher
More informationCaring for the Poisoned Patient
#34442 Caring for the Poisoned Patient COURSE #34442 5 CONTACT HOURS Release Date: 04/01/18 Expiration Date: 03/31/21 Caring for the Poisoned Patient HOW TO RECEIVE CREDIT Read the enclosed course. Complete
More informationSTEMI Care 2014 at the Crossroads: Taking the right road
STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,
More informationToxicology General Approach to the Poisoned Patient James Sinex, MD., FACEP
General Approach to the Poisoned Patient James Sinex, MD., FACEP Definition of Terms Poisoning can be defined as exposure to a chemical or other agent that adversely affects functioning of an organism.
More informationOHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST
11/5/2018 OHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST Test Critical Low Critical High Alerting CHEMISTRY Amylase > 400 U/L Emergency Dept
More informationSHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?
SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE
More information35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough
The following are a list by department of Critical (Panic) Values: CHEMISTRY TEST LESS THAN GREATER THAN UNITS Glucose 0-7days 40 200 mg/dl Glucose > 7 days 50 400 mg/dl Glucose, CSF 25 mg/dl Sodium 121
More informationChapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications
Chapter 13 Poisonings, Overdoses, and Intoxications Learning Objectives Discuss use of activated charcoal in treatment of poisonings List treatment options for acetaminophen overdose List clinical manifestations
More informationEHRA Position Documents on new technology or standards of care
EHRA Position Documents on new technology or standards of care Prof. Laurent Fauchier Cardiologie, Centre Hospitalier Universitaire Trousseau Tours, France Disclosures Laurent Fauchier: Lecture fees: Bayer,
More informationESC Heart & Brain Workshop
ESC Heart & Brain Workshop Carotid Stenosis - selecting the high risk patients for intervention Alison Halliday, Professor of Vascular Surgery, University of Oxford 20 th January 2018, Prague ESC Workshop
More informationTest Critical Low Critical High Alerting Category
Test Critical Low Critical High Alerting CHEMISTRY Amylase > 400 U/L Emergency Dept only Amylase, Pancreatic >300 U/L Emergency Dept only Bicarb (Carbon Dioxide) 40 mmol/l Bilirubin, Total
More informationMartin R Cowie Professor of Cardiology, National Heart & Lung Institute Imperial College London (Royal Brompton Hospital)
Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure and Reduced Ejection Fraction (SERVE-HF) Martin R Cowie Professor
More informationQuality Indicators in Chronic Pain Management
Disclosures (2008-2013): 1. Employment: Heidelberg University 2. Advisor: Allergan, Astellas, Astra-Zeneca, Boehringer Ingelheim, Galderma, Glaxo Smith Kline, Grünenthal, Lilly, Merz, Merck-Sharpe & Dohme,
More informationHeart Failure in Women
Heart Failure in Women Disclosure Professor Sindone has received honoraria, speaker fees, consultancy fees, is a member of advisory boards or has appeared on expert panels for: Professor Andrew Sindone
More informationSalicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes
Salicylate (Aspirin) Ingestion California Poison Control 1-800-876-4766 Background 1. The prevalence of aspirin-containing analgesic products makes these agents, found in virtually every household, common
More informationAccidental poisoning in children & adolescents in Hong Kong
Accidental poisoning in Hong Kong Accidental poisoning in children & adolescents in Hong Kong Dr. Fei-lung Lau Director Hong Kong Poison Information Centre UCH Toxicology Training Centre Hong Kong Poison
More informationNadine Ajzenberg** Marie-Genevieve Huisse** Isabelle Mahé*** Edith Peynaud **** Aurelie Roche* Patricia Esselin* Laurence Auguste-Charlery*
«new oral anticoagulants and brain specificity» Claire Bal dit Sollier * Ariane Davout * Sun-Young Park* Irène Clavijo* Adeline-Zoe Thoux * Ioana Muller* Ludovic Drouet* Nadine Ajzenberg** Marie-Genevieve
More informationElectrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine
Electrolyte Imbalance and Resuscitation Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine Presentation plan Definition of the electrolyte disturbances Conditions
More informationDamn it Jim, I m an EMT not a Doctor. EMS Drug-Drug interactions and how not to be the grim reaper
Damn it Jim, I m an EMT not a Doctor EMS Drug-Drug interactions and how not to be the grim reaper OBJECTIVES Examine EMS drugs and the interactions they have with other medications. Describe potential
More informationAnne Carol Goldberg, MD, FACP, FAHA, FNLA Washington University, St. Louis, MO USA
Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardiovascular Risk: The CLEAR Wisdom Trial Anne Carol Goldberg, MD, FACP, FAHA,
More informationRicky Bell Renal/ICM Registrar
Ricky Bell Renal/ICM Registrar Objectives When to call renal How to manage the patient with AKI How the manage the patient with CKD (HD/PD) Special AKI situations What do the guidelines say? My referral
More informationJOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS. Always call results for the following test(s):
Facilities: NoCo Laboratories JOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS Always call results for the following test(s): CONSTITUENT Ethylene Glycol (Performed at CU) Time Interval (from
More informationURINE DRUGS OF ABUSE SCREEN, THYROID STIMULATING HORMONE, AND VITAMIN B12 ORDERING IN THE EMERGENCY DEPARTMENT: JOINT POLICY STATEMENT
URINE DRUGS OF ABUSE SCREEN, THYROID STIMULATING HORMONE, AND VITAMIN B12 ORDERING IN THE EMERGENCY DEPARTMENT: JOINT POLICY STATEMENT Shared Health, Diagnostic Services Dr. A. Kabani Dr. A. Sokoro, Lead
More informationHow effective is chelation? contrasts in iron and digoxin poisoning. Nick Bateman Edinburgh
How effective is chelation? contrasts in iron and digoxin poisoning Nick Bateman Edinburgh Chelation Chemical chelating agents chemical that bind metal ions and other toxic groups e.g. desferrioxamine
More informationSmall Doses, Big Problems: Deadly Pediatric Poisons
Small Doses, Big Problems: Deadly Pediatric Poisons Adam Algren, MD Departments of Pediatrics and Emergency Medicine Children s Mercy Hospital and Truman Medical Center Medical Director University of Kansas
More informationFrench Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction FAST-MI 2010
French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010 Registry Michel Hanssen, 1 Yves Cottin, 2 Khalife Khalife, 3 Laure Hammer, 4 Patrick Goldstein, 5 Etienne
More informationAF detection: What s new? Christopher B. Granger
AF detection: What s new? Christopher B. Granger Disclosures Research contracts: Apple, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Janssen, Novartis, GSK, Medtronic Foundation, Pfizer,
More informationGuidelines for the Management of Dyslipidaemias
Guidelines for the Management of Dyslipidaemias Etienne PUYMIRAT Département de Cardiologie Hôpital Européen Georges Pompidou Université Paris Descartes, Paris, France Fees for lectures and/or consulting:
More informationUsefulness of hand-held ultrasound devices in out-of-hospital diagnosis performed by emergency physicians
American Journal of Emergency Medicine (2006) 24, 237 242 www.elsevier.com/locate/ajem Diagnostics Usefulness of hand-held ultrasound devices in out-of-hospital diagnosis performed by emergency physicians
More informationConflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot
Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot Agrément FMC N 100 437 Popul. millions Area km2 Density inha/km2
More informationThe plan. Overview of clinical trials Current clinical trials in renal cancer Future treatment of renal cancer
Relevant disclosure Bayer - consultancy GSK research funding, consultancy, speaker honoraria Novartis research funding Pfizer research funding, consultancy Roche / Genentech research funding, consultancy
More informationACUTE & CHRONIC ETHANOL EFFECTS An Overview
ACUTE & CHRONIC ETHANOL EFFECTS An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Clinical Biochemistry: PBL Seminar MBBS Yr 4 VJ Temple
More informationFinancial/Commercial Relationships & Conflicts of Interest DISCLOSURES
Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES All individuals able to influence or control content of any CME certified activity that will be presented were required to complete
More informationUtility of Pharmacogenomics to Identify and Limit CV Risk. Christopher B. Granger, MD
Utility of Pharmacogenomics to Identify and Limit CV Risk Christopher B. Granger, MD Disclosure Research contracts: AstraZeneca, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, The Medicines Company, and Boehringer
More information